Abstract: Zika virus (ZIKV), an emerging flavivirus which causes neurodevelopmental impairment
syndrome (CZS), and even fetal demise [2] . While most cases of ZIKV infection are asymptomatic, reports of rash, conjunctivitis, pain in the muscles or joints, and fever have been recorded in clinical group of compound 2 was obtained by hydrogenation of the alkyne using 5% Pd/BaSO4 in (1:1) quinoline/benzene without the loss of the benzoyl protecting groups [28] . Ribosylation of uracil to 98 compound 2 using BSA and SnCl4 in ACN afforded benzoyl-protected 2'-C-ethenyluridine 3. The deprotection of compound 3 was performed using NH3/MeOH in MeOH to afford 2'-C-100 ethenyluridine 4, which was then treated with tBuMgCl in THF followed by N- [ 
134
(208.7 mg, 0.362 mmol, 1 equiv.) in benzene (2 mL) and ethanol (2 mL) under H2 (g) was added 5%
135
palladium on barium sulfate (20.8 mg, 10 wt%) followed by quinolone (22 µL) and was stirred at 136 room temperature for 2 hours. The mixture was diluted in ethyl acetate, washed 3 times with water,
137
and dried over anhydrous sodium sulfate. The reaction mixture was purified using flash 
158
Compound 3 (90.5 g, 0.155 mmol, 1 equiv.) was dried overnight on high vacuum. Under N2 (g) was
159
added methanol (1.5 mL) then the reaction mixture was cooled to 0°C followed by dropwise addition 160 of sodium methoxide (86.5 µL, 1.553 mmol, 10 equiv. 
180
( 
215
The GSC 387 cell line was prepared and maintained similarly to what has been previously described 216 using the media and detachment conditions used for hNSCs described above [29] . Vero cells (ATCC
217
CCL-81) were purchased from ATCC and cultured in Dulbecco's Modified Eagle Medium (DMEM)
218
(Gibco) with high glucose (4.5g/L), 10% fetal calf serum (FCS) (Sigma), and 1% Penicillin-
219
Streptomycin (PS) (Sigma-Aldrich) at 37°C and 5% CO2.
221

Viruses
222
Viral strains used in this study were provided through BEI Resources, NIAID, NIH: Zika virus 
ZIKV RdRP expression and purification
265
The RdRP domain of ZIKV NS5 (amino acids 2772-3423 of accession number AMB18850) was
266
fused to an N-terminal 6x-histidine tag containing a TEV cleavage site, and the cDNA was codon- were then harvested by centrifugation at 9,000 RPM for 30 min at 4ºC, and pellets were stored at - 
296
Single nucleotide incororation assays were modeled from previous work [19] . Briefly, ZIKV
297
RdRP (1 µM) and P/T substrate (200 nM) were pre-incubated at 37ºC for 20 min. Reactions were 298 initiated at 37ºC with the addition of 150 µM UTP or analog in 50 mM HEPES pH 7.5, 15% glycerol,
299
15 mM NaCl, 7.5 mM MnCl2, and 10 mM dithiothreitol. At specified time points, reaction aliquots
300
were quenched with ethylenediamine tetra-acetic acid (EDTA) to a final concentration of 0.3 M.
0.01% xylene cyanol, 0.01% bromophenol blue) and 1 µL of 5 µM D10 (5'-AGTTGTTGAT) trap,
304
followed by incubation at 95°C for 5 min. 
361
Activity against ZIKV and toxicity of nucleoside analogue ProTides in human neural stem cells
362
To profile the activity and toxicity profiles of our library of ProTides, we screened compounds 
416
At 30 µM compound, both 2'-C-methyluridine aryloxyl phosphoramidate ProTide and sofosbuvir
417
were able to repress viral titers to undetectable levels. However, only 2'-C-methyluridine aryloxyl
418
phosphoramidate ProTide was able to reduce ZIKV titers to undetectable levels at 10 µM 419 compound, again highlighting its superior antiviral activity compared to sofosbuvir. 
491
We also observed that changing the ProTide functionality of 2'-C-methyluridine from an 
495
ProTide functionalities and the cell type dependence of their antiviral activity, as well as testing the 496 impact of these effects using in vivo animal model testing are planned in our research groups.
will guide future work to design highly selective, safe and bioavailable compounds for the treatment of ZIKV infections. 
